CD40 Ligand antibody (FITC)
Quick Overview for CD40 Ligand antibody (FITC) (ABIN610379)
Target
See all CD40 Ligand (CD40LG) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Immunoprecipitates a CD154 (gp39) molecule of about 39 kd.
-
Purification
- Protein A purified
-
Immunogen
-
Human sgp39 fusion protein.
Type of Immunogen: Fusion protein -
Isotype
- IgG1
-
-
-
-
Application Notes
-
Approved: ELISA, Flo, Func, IHC, WB
Usage: Function: Blocks MLR, sgp39 induced human B cell proliferation and T cell dependent B cell differentiation. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride, 5 % Glycerol, 0.2 % BSA, 0.04 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Do not freeze. Product is photosensitive and should be protected from light.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C. Do not freeze. Protect from light.
-
-
-
Friends and family: the role of the Rab GTPases in vesicular traffic." in: Cell, Vol. 75, Issue 4, pp. 597-601, (1993) (PubMed).
: "
-
Friends and family: the role of the Rab GTPases in vesicular traffic." in: Cell, Vol. 75, Issue 4, pp. 597-601, (1993) (PubMed).
-
- CD40 Ligand (CD40LG)
-
Alternative Name
- CD40LG / CD40L / CD154
-
Background
-
Name/Gene ID: CD40LG
Family: TNF
Synonyms: CD40LG, CD154, CD154 antigen, CD40-L, CD40 ligand, CD40L, gp39, HIGM1, IGM, IMD3, T-BAM, TNFSF5, CD40 antigen ligand, CD54, HCD40L, T-B cell-activating molecule, T-cell antigen Gp39, TNF-related activation protein -
Gene ID
- 959
-
UniProt
- P29965
-
Pathways
- NF-kappaB Signaling, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-